Shopping Cart
- Remove All
- Your shopping cart is currently empty
SSTR5 antagonist 2 TFA is a highly potent, oral active and selective antagonist of somatostatin (receptor) subtype 5 (SSTR5), with potential to treat type 2 diabetes mellitus (T2DM).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,820 | 10-14 weeks | |
50 mg | $2,380 | 10-14 weeks | |
100 mg | $3,100 | 10-14 weeks |
Description | SSTR5 antagonist 2 TFA is a highly potent, oral active and selective antagonist of somatostatin (receptor) subtype 5 (SSTR5), with potential to treat type 2 diabetes mellitus (T2DM). |
In vivo | In mice at a dose of 10 mg/kg,SSTR5 antagonist 2 (10 mg/kg, orally) increases both total and active circulating incretin hormone GLP1 levels . SSTR5 antagonist 2 increases pancreatic insulin secretion as well as total and active GLP1 release, and demonstrates synergistic effects in combination with DPP4 inhibitors. |
Molecular Weight | 660.65 |
Formula | C34H36F4N2O7 |
Cas No. | 1254733-98-6 |
Relative Density. | 1.31g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.